Report cover image

UK Retail And Clinical Wellness Market Size, Share & Trends Analysis Report By Type (Core Clinical Wellness, Preventive Health & Diagnostics, Lifestyle & Preventive Nutrition, Mental Wellbeing & Sleep Health, Digital Health & Connected Wellness), And Segm

Publisher Grand View Research
Published Dec 16, 2025
Length 100 Pages
SKU # GV20723822

Description

UK Retail & Clinical Wellness Market Summary

The UK retail and clinical wellness market size was estimated at USD 53.01 billion in 2025 and is expected to reach an estimated value of USD 74.79 billion by 2033, growing at a CAGR of 4.42% from 2026 to 2033. Key market growth drivers include the increasing focus on prevention and self-care, the rising use of privately funded healthcare and wellness services, the growing adoption of e-commerce, digital health & technology-enabled wellness, and the increasing demand for evidence-based, “clinical-grade” wellness and quality assurance.

Rising consumer interest in preventive health and self-care is driving demand in the market. Shoppers are increasingly purchasing vitamins, functional foods, at-home diagnostics, wearables, and apps, while also seeking accessible clinical services to avoid hospital visits. This willingness to invest in wellbeing, including nutrition, sleep, mental health, and fitness, is boosting sales of health-focused groceries, over-the-counter products, and digital subscriptions, creating new opportunities and margins for retailers.

UK Retail And Clinical Wellness Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the UK retail and clinical wellness market report based on type:
  • Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Core Clinical Wellness
  • Pharmacy Services
  • Optical Services
  • Preventive Health & Diagnostics
  • Preventive Screenings
  • At-home & In-store Diagnostics
  • Digital Health Assessments
  • Lifestyle & Preventive Nutrition
  • Vitamins & Dietary Supplements (VDS)
  • Sports & Weight Management Nutrition
  • Personalized Nutrition & Gut Health
  • Mental Wellbeing & Sleep Health
  • Mental Wellness & Stress Management
  • Sleep & Relaxation
  • Women’s, Men’s & Family Health
  • Women’s Health
  • Men’s Health
  • Pediatric & Family Wellness
  • Digital Health & Connected Wellness
  • Teleconsultation & Online Doctor Services
  • Chronic Disease Management Platforms
  • Mental & Behavioral Health Apps
  • Women’s Digital Health
  • AI-Powered Health Tracking & Preventive Tools
  • Audiology & Hearing Care
  • Hearing Assessments & Screening
  • Hearing Aid Dispensing & Fitting
  • Aftercare & Maintenance Services
  • Digital Audiology & Remote Hearing Care
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source type
1.2.2. Sales type
1.2.3. End use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source type outlook
2.2.2. Sales type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Cannabidiol Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing legalization of CBD-based products
3.2.1.2. Increasing preference for cannabis oils and tinctures
3.2.1.3. Growing adoption of CBD-based products for treating various medical conditions
3.2.1.4. Rise in the number of retailers selling CBD-based products
3.2.2. Market restraint analysis
3.2.2.1. Stringent government regulations
3.2.2.2. Absence of legalization programs in several Asian and African countries
3.2.2.3. High cost of CBD in leading markets
3.3. Cannabidiol: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Market Trends
3.4.1. Introduction of New Cannabis Products
3.4.2. Celebrity Cannabis Engagement
3.4.3. Growing Popularity of Craft and Boutique Cannabis Brands
3.4.4. Improved Cannabis Cultivation and Distribution Technology
3.4.5. Federal and State Cannabis Policy Opportunities
3.5. Regulatory Scenario by Country
3.6. Jurisdiction Analysis by Country
3.7. Cannabis Ecophysiology Analysis
3.7.1. Key Environmental Parameters and their Impact Analysis
3.7.2. Commercial Implications
3.7.3. Technological Integration
3.7.4. Market Relevance
3.8. Cannabis Consumption Pattern Analysis, by region
3.9. Legal Cannabis Potential Trade Opportunity, by region
3.9.1. Global Legal Marijuana Trade Route
3.9.2. Global Hemp Trade Route
3.10. List of Countries Importing Hemp
3.10.1. Top Five Countries That Import Yarn of hemp (cannabis sativa L.) and Their Trade Values
3.11. List of Countries Exporting Hemp
3.11.1. Top Five Countries That Export Yarn of hemp (cannabis sativa L.) and Their Trade Values
3.12. List of Countries Importing and Exporting Medical Cannabis
3.12.1. List of Countries Importing Cannabis Oils
3.12.2. List of Countries Exporting Cannabis Oils
3.12.3. List of Countries Importing Hemp Seed
3.12.4. List of Countries Exporting Hemp Seed
3.12.5. List of Countries Importing Cannabis Flowers
3.12.6. List of Countries Exporting Cannabis Flowers
3.13. Legal Cannabis Seed to Shelf Story
3.13.1. Section Description
3.13.2. Cultivators & Growers
3.13.3. Manufacturers & Producers
3.13.4. Testers
3.13.5. Wholesalers & Distributors
3.13.6. Retailers
3.13.7. Supply Chain Analysis
3.13.8. Supply Chain Network from Hemp Cultivators to CBD Consumer Products
3.13.9. Supply Chain Network of Hemp Biomass to Industrial Applications
3.13.10. Supply Chain Network from Marijuana Plants to Marijuana Oil
3.14. Profit Margin Analysis
Chapter 4. Cannabidiol Market: Source Type Estimates & Trend Analysis
4.1. Source Type Market Share, 2025 & 2033
4.2. Segment Dashboard
4.3. Global Cannabidiol Market by Source Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Hemp
4.4.1.1. Hemp market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Marijuana
4.4.2.1. Marijuana market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Cannabidiol Market: Sales Type Estimates & Trend Analysis
5.1. Sales Type Market Share, 2025 & 2033
5.2. Segment Dashboard
5.3. Global Cannabidiol Market by Sales Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.4.1. Business to Business (B2B)
5.4.1.1. Business to business (B2B) market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.2. By End-use
5.4.1.3. Pharmaceuticals
5.4.1.3.1. Pharmaceuticals market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.4. Wellness
5.4.1.4.1. Wellness market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.5. Food & Beverages
5.4.1.5.1. Food & Beverages market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.6. Personal Care & Cosmetics
5.4.1.6.1. Personal Care & Cosmetics market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.7. Nutraceuticals
5.4.1.7.1. Nutraceutical market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.8. Others
5.4.1.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Business to Consumer (B2C)
5.4.2.1. Business to consumer (B2C) estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2. By Sales Channel
5.4.2.3. Hospital Pharmacies
5.4.2.3.1. Hospital pharmacies market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.4. Online Stores
5.4.2.4.1. Online stores market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.5. Retail Stores
5.4.2.5.1. Retail stores market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.6. By End-use
5.4.2.7. Medical
5.4.2.7.1. Medical market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.7.2. Chronic Pain
5.4.2.7.2.1. Chronic pain market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.7.3. Mental Disorders
5.4.2.7.3.1. Mental disorders market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.7.4. Cancer
5.4.2.7.4.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.7.5. Others
5.4.2.7.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.8. Personal Use
5.4.2.8.1. Personal use market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Cannabidiol Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2025 & 2033
6.2. Segment Dashboard
6.3. Global Cannabidiol Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. Medical
6.4.1.1. Medical market estimates and forecasts 2021 to 2033 (USD Million)
6.4.1.2. Chronic Pain
6.4.1.2.1. Chronic pain market estimates and forecasts 2021 to 2033 (USD million)
6.4.1.3. Mental Disorders
6.4.1.3.1. Mental disorders market estimates and forecasts 2021 to 2033 (USD million)
6.4.1.4. Cancer
6.4.1.4.1. Cancer market estimates and forecasts 2021 to 2033 (USD million)
6.4.1.5. Others
6.4.1.5.1. Others market estimates and forecasts 2021 to 2033 (USD million)
6.4.2. Personal Use
6.4.2.1. Personal use market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Pharmaceutical
6.4.3.1. Pharmaceutical market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Wellness
6.4.4.1. Wellness market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4.2. Food & Beverages
6.4.4.2.1. Food & beverages market estimates and forecasts 2021 to 2033 (USD million)
6.4.4.3. Personal Care & Cosmetics
6.4.4.3.1. Personal care & cosmetics market estimates and forecasts 2021 to 2033 (USD million)
6.4.4.4. Nutraceuticals
6.4.4.4.1. Nutraceuticals market estimates and forecasts 2021 to 2033 (USD million)
6.4.4.5. Others
6.4.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD million)
Chapter 7. Cannabidiol Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. France market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. Switzerland
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Switzerland market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. The Netherlands
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Netherlands market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7. Poland
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Poland market estimates and forecasts 2021 to 2033 (USD Million)
7.6.8. Czech Republic
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Czech Republic market estimates and forecasts 2021 to 2033 (USD Million)
7.6.9. Croatia
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework
7.6.9.3. Croatia market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. China market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. India market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework
7.7.5.3. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.7.6. New Zealand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework
7.7.6.3. New Zealand market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4. Colombia
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.5. Uruguay
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Uruguay market estimates and forecasts 2021 to 2033 (USD Million)
7.8.6. Chile
7.8.6.1. Key country dynamics
7.8.6.2. Regulatory framework
7.8.6.3. Chile market estimates and forecasts 2021 to 2033 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework
7.9.1.3. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.9.2. Israel
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework
7.9.2.3. Israel market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. ENDOCA
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Cannoid, LLC
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Medical Marijuana, Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Folium Europe B.V.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Canopy Growth Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Elixinol
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. NuLeaf Naturals, LLC
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Isodiol International, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. PharmaHemp
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. The Cronos Group
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us